Vanguard Group Inc Stoke Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,946,258 shares of STOK stock, worth $75.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,946,258
Previous 2,784,202 5.82%
Holding current value
$75.3 Million
Previous $18.5 Million 80.62%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$5.9 - $11.84 $956,130 - $1.92 Million
162,056 Added 5.82%
2,946,258 $33.4 Million
Q1 2025

May 09, 2025
BUY
$6.65 - $12.74 $352,476 - $675,270
53,004 Added 1.94%
2,784,202 $18.5 Million
Q4 2024

Feb 11, 2025
SELL
$10.8 - $13.92 $302,929 - $390,442
-28,049 Reduced 1.02%
2,731,198 $30.1 Million
Q3 2024

Nov 13, 2024
BUY
$12.24 - $15.92 $876,249 - $1.14 Million
71,589 Added 2.66%
2,759,247 $33.9 Million
Q2 2024

Aug 13, 2024
BUY
$11.03 - $17.52 $10.7 Million - $17 Million
972,104 Added 56.66%
2,687,658 $36.3 Million
Q1 2024

May 10, 2024
BUY
$4.12 - $14.17 $276,254 - $950,126
67,052 Added 4.07%
1,715,554 $23.2 Million
Q4 2023

Feb 14, 2024
BUY
$3.37 - $5.4 $60,033 - $96,195
17,814 Added 1.09%
1,648,502 $8.67 Million
Q3 2023

Nov 14, 2023
BUY
$3.78 - $11.99 $90,357 - $286,608
23,904 Added 1.49%
1,630,688 $6.42 Million
Q2 2023

Aug 14, 2023
BUY
$7.93 - $13.82 $3.77 Million - $6.56 Million
474,797 Added 41.94%
1,606,784 $17.1 Million
Q1 2023

May 15, 2023
SELL
$7.65 - $10.38 $3.6 Million - $4.88 Million
-470,058 Reduced 29.34%
1,131,987 $9.43 Million
Q4 2022

Feb 10, 2023
SELL
$7.07 - $15.69 $3.15 Million - $7 Million
-445,859 Reduced 21.77%
1,602,045 $14.8 Million
Q3 2022

Nov 14, 2022
BUY
$12.56 - $22.53 $664,059 - $1.19 Million
52,871 Added 2.65%
2,047,904 $26.3 Million
Q2 2022

Aug 12, 2022
BUY
$10.36 - $23.93 $576,461 - $1.33 Million
55,643 Added 2.87%
1,995,033 $26.4 Million
Q1 2022

May 13, 2022
BUY
$17.19 - $26.1 $467,705 - $710,128
27,208 Added 1.42%
1,939,390 $40.8 Million
Q4 2021

Feb 14, 2022
BUY
$18.11 - $30.72 $1.17 Million - $1.98 Million
64,567 Added 3.49%
1,912,182 $45.9 Million
Q3 2021

Nov 12, 2021
BUY
$23.65 - $34.44 $2.57 Million - $3.75 Million
108,813 Added 6.26%
1,847,615 $47 Million
Q2 2021

Aug 13, 2021
BUY
$30.53 - $41.09 $53.1 Million - $71.4 Million
1,738,802 New
1,738,802 $58.5 Million

Others Institutions Holding STOK

# of Institutions
139
Shares Held
57.6M
Call Options Held
2.7K
Put Options Held
57.4K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $1.01B
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email